Skip to contentW
Whitehawk Therapeutics, Inc.
W
WHWKWhitehawk Therapeutics, Inc. Released Nov 14, 2016, during market hours
10-Q filed Nov 14, 2016, 45 days after period end · 0001213900-16-018356
Q3 2016 · 10-Q
Revenue—
Net Income-$4.89M-$4.89MN/M vs Q3 2015N/M vs Q2 2016 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
-$6.69-$6.69
N/M vs Q2 2016
Operating Income-$4,745,315N/M Operating Cash Flowderived-$12,442N/M Free Cash Flowderived-$12,442— Filing lag
ended Sep 30, 2016 · filed Nov 14, 2016 · 45 d after period end